Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE: 688553)
Health Care · Pharmaceuticals · CN
CN¥11.92
-4.41% today · -36.1% 1Y
Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE: 688553) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.11B and employs 1,366 people.
Over the last twelve months the share price has lost 36.1%, trading between 9.61 and 19.11.
Tweenvest scores Sichuan Huiyu Pharmaceutical Co., Ltd. across four factors: quality 65/100, value 38/100, growth 0/100, dividend 31/100. Its strongest factor is quality.
688553 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.11B
- Revenue (TTM)
- $161.48M
- P/E
- 76.12
- EPS
- 0.16
- Dividend yield
- 1.13%
- Beta (5Y)
- 0.51
- 52-week high
- CN¥19.11
- 52-week low
- CN¥9.61
- Avg volume (3M)
- —
- Shares outstanding
- 623.76M
- Employees
- 1,366
- Next earnings
- —
About Sichuan Huiyu Pharmaceutical Co., Ltd.
Sichuan Huiyu Pharmaceutical Co., Ltd., established in 2010 and headquartered in Neijiang, China, is actively involved in the entire pharmaceutical process. This includes the research, development, manufacturing, and commercialization of medications. The company's core specialization is in anti-tumor therapies and injectable drugs, catering primarily to the oncology sector and related medical disciplines, but also extending its offerings to other therapeutic areas.
- Founded
- 2010
- Listed since
- Oct 26, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.